Keyphrases
Glioma
100%
Doxorubicin
100%
Immune Regulation
100%
PD-1 Blockade
100%
Low-intensity Pulsed Ultrasound (LIPUS)
100%
Ultrasound-mediated Drug Delivery
100%
Ultrasound Microbubbles
85%
Anti-PD-1 Antibody
71%
Glioblastoma
57%
MHC Class II
42%
Blood-brain Barrier
28%
Tumor Cells
14%
Myeloid Cells
14%
Macrophages
14%
Brain Regions
14%
Fold Increase
14%
Lymphocytes
14%
Microglia
14%
Translational Studies
14%
Study Support
14%
Long-term Survival
14%
Pembrolizumab
14%
Microbubbles
14%
Peritumoral
14%
Antibody Concentration
14%
Blood-brain Barrier Disruption
14%
Brain Concentration
14%
Pegylated Liposomal Doxorubicin
14%
Antitumoral Activity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Blocking Antibody
71%
Glioblastoma
57%
Blood-Brain Barrier
42%
Pembrolizumab
14%
Long Term Survival
14%
Neoplasm
14%
Neuroscience
Doxorubicin
100%
Blocking Antibody
71%
Blood Brain Barrier
42%
Major Histocompatibility Complex
28%
Myeloid
14%
Lambrolizumab
14%
Macrophage
14%
Microglia
14%
Lymphocyte
14%